The impact of technology on health and medicine is a key focus of the ÐÓ°ÉÂÛ̳ Law, Technology and Society group. The group brings together experts in medical law, intellectual property law, the regulation of medicines and medical devices, data protection, synthetic biology, food marketing and human genome studies. Members of the technology, health and medicine sub-group have played important roles in national and international bodies, like the Human Fertilisation and Embryology Authority, the UK Commission on Intellectual Property rights, the European Commission and the UN.
The technology, health and medicine group provide regulator keynote speakers, expert witnesses and roundtable experts to global conferences, workshops and inquiries. Members of the group have acted sat on committees including the Belgian Working Group on Unhealthy Food Marketing and Children, and the British Medical Association Medical Ethics Committee, and have served as advisers to the Nuffield Council on Bioethics.
The group have published extensively in this field including books such as Professor Jackson’s Law and the Regulation of Medicines, The Regulation of Reproduction and Medical Law. Members of the group have produced expert reports, such as a fact-finding Study on How Domestic Measures Address Benefit-sharing arising from Commercial and Non-commercial use of Digital Sequence Information on Genetic Resources for Research and Development, for the Convention on Biological Diversity. The group also contributes regularly to the ÐÓ°ÉÂÛ̳ Law Policy Briefing Series, including Professor Jackson’s paper , and Dr Thambisetty’s and .
Staff in the Technology, Health and Medicine Group
Professor Emily Jackson
Dr Luke McDonagh
Dr Siva Thambisetty